









Markets
/
Stocks
/
nasdaq-hscs
/

HeartSciences Inc

HSCS

2.830USD

-0.100-3.41%

Close 11/04, 16:00（ET）Quotes delayed by 15 min

6.46MMarket Cap

LossP/E TTM



HeartSciences Inc

2.830

-0.100-3.41%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of HeartSciences Inc

Currency: USD Updated: 2025-11-04

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

HeartSciences Inc's Score

Industry at a Glance

Industry Ranking

147 / 210

Overall Ranking

366 / 4616

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 2 analysts

Buy

Current Rating

13.500

Target Price

+360.75%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

HeartSciences Inc Highlights

StrengthsRisks

HeartSciences Inc. is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The Company has libraries of artificial intelligence-enhanced electrocardiography (AI-ECG) algorithms and is developing AI-ECG solutions to be made available on either a hardware- agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction, which has traditionally only been available through the use of cardiac imaging. The MyoVista also provides conventional ECG information in the same test. It delivers AI-ECG algorithms using existing ECG devices across a hospital or health system.

Growing

The company is in a growing phase, with the latest annual income totaling USD 4.35K.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 4.35K.

Fairly Valued

The company’s latest PE is -0.34, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 61.60K shares, increasing 4.21% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 1.32K shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-04

The company's current financial score is 6.60, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is weak, and its operating efficiency is low.

Score

Industry at a Glance

Previous score

6.60

Change



Financials

5.54

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.36

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

2.72

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

9.83

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.54

Key Metrics

Free cash flow

No Data

HeartSciences Inc's Company Valuation

Currency: USD Updated: 2025-11-04

The company’s current valuation score is 5.61, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -0.34, which is -99.62% below the recent high of -0.00 and -1358.51% above the recent low of -4.99.

Score

Industry at a Glance

Previous score

5.61

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 147/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-04

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for HeartSciences Inc is 13.50, with a high of 15.00 and a low of 12.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 2 analysts

Buy

Current Rating

13.500

Target Price

+360.75%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

HeartSciences Inc

HSCS

Boston Scientific Corp

BSX

Intuitive Surgical Inc

ISRG

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-04

The company’s current price momentum score is 2.30, which is lower than the Healthcare Equipment & Supplies industry's average of 6.77. Sideways: Currently, the stock price is trading between the resistance level at 3.47 and the support level at 2.49, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

2.29

Change

0.01

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(5)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.105

Sell

RSI(14)

29.065

Sell

STOCH(KDJ)(9,3,3)

9.120

Oversold

ATR(14)

0.158

Low Volatility

CCI(14)

-131.508

Sell

Williams %R

95.061

Oversold

TRIX(12,20)

-0.652

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

2.948

Sell

MA10

3.100

Sell

MA20

3.304

Sell

MA50

3.411

Sell

MA100

3.585

Sell

MA200

3.481

Sell

Institutional Confidence

Currency: USD Updated: 2025-11-04

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.39. The latest institutional shareholding proportion is 2.01%, representing a quarter-over-quarter decrease of 69.40%. The largest institutional shareholder is The Vanguard, holding a total of 1.32K shares, representing 0.04% of shares outstanding, with 78.05% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Icahn School of Medicine at Mount Sinai

48.55K

Matthews (John H)

39.73K

Astoria Strategic Wealth, Inc.

18.93K

Citadel Advisors LLC

18.68K

Geode Capital Management, L.L.C.

11.60K

+23.21%

Advisory Services Network, LLC

10.00K

Simpson (Andrew)

4.38K

The Vanguard Group, Inc.

Star Investors

1.32K

Tower Research Capital LLC

665.00

-51.92%

Desjardins Securities Inc.

400.00

Risk Assessment

Currency: USD Updated: 2025-11-04

The company’s current risk assessment score is 2.60, which is lower than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 2.58. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.